Close MyAccount Menu
The Federal Council of Russia adopted the amendments to the Tax Code (to Article 95, part I and to Article 5 of the Federal law # 395-FZ), aimed at developing favorable tax environment for innovative activities. In particular, the new provisions include:
The Head of the Ministry for Healthcare and Social Development Tatiana Golikova and the Health Minister of Republic of Belarus Vassily Zharko signed a treaty on cooperation in the field of healthcare and medical science. In particular, the parties agreed on consolidating the efforts on developing the medical goods and pharmaceuticals production, inter alia, by setting up joint ventures.
The powers of the Department include control over the pricing for essential drugs applied by pharmaceutical wholesalers, pharmacies and individual entrepreneurs licensed for pharmaceutical activity.
Pursuant to the Resolution, the primary goal for transferring the functions is to improve the management system in the area of pharmaceuticals support to Moscow citizens and to enhance the city’s authorities’ powers in part of enforcing the state pricing regulation for pharmaceuticals.
The list includes information on medical equipment producers and the equipment cost. The prices for domestic medical equipment are presented as ex-factory prices including VAT and are supposed be the maximum ex-factory prices to be applied by manufacturers for the standard package of equipment with a warranty period of from 1 to 5 years.
The list is expected to allow purchasing the competitive Russia-manufactured medical equipment under regional programs for healthcare modernization.
The law shortens the list of activities subject to licensing. In particular, manufacturing and technical maintenance of medical equipment do not require license anymore.
The Federal law dd. 8 August 2001 No 128-FZ "On licensing the particular types of activities" is repealed.
The new list of drugs contains no restrictions by pharmaceutical form (capsules, aerosols, etc.), which is supposed to increase the share of Russia-manufactured pharmaceuticals involved into the program from 10% to 25%.
The total savings on purchases of such drugs could comprise, as per different experts’ estimates, up to 2 billion rubles (almost 3% of the total costs).
Commenting on the amendments approved by the President, the Head of the Ministry for Healthcare and Social Development Tatiana Golikova noted that in the past there were frequent cases of offering used equipment in state tenders. The adopted legislative amendments should preclude such situations.
Also, the new law obliges the customer to justify the maximum starting price of the contract. In particular, the tender documentation shall specify the sources of information used for determining the prices for the equipment to be purchased.
The Federal Customs Service of Russia signed an agreement on informative cooperation with a non-commercial partnership "Self-regulatory organization supporting the distribution of high-quality pharmaceuticals in the market "The standards of the pharmaceutical market” (NP SRO "SFR").
In particular, it is intended to develop an online system for exchanging the data on the registered participants of international trade and on the declarations of conformity for the imported drugs. As a result, it is expected to reduce the volume of documents submitted to the customs authorities during the electronic declaration of goods.
Creation of the common information resource should allow identifying all the pharmaceuticals entering the Russian market, obtaining precise data on the volumes of purchased and shipped drugs as well as monitoring the title transfer within the supply chain.
MN – KPMG Mongolia – © 2018 KPMG Audit LLC, the Mongolian member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity.